| Line Item | 2025-03-31 | Y/Y |
|---|---|---|
| Revenue | $362.5M | — |
| Cost of Revenue | $168.0M | — |
| Gross Profit | $194.5M | — |
| R&D Expense | $16.1M | — |
| SG&A Expense | $204.4M | — |
| Operating Income | -$25.9M | — |
| Pre-tax Income | -$46.5M | — |
| Income Tax | $4.5M | — |
| Net Income | -$51.0M | -698.8% |
| Line Item | 2025-03-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $44.4M | +82.3% |
| Accounts Receivable | $78.6M | +159.2% |
| Inventory | $18.4M | -15.3% |
| Current Assets | $169.1M | -0.4% |
| Total Assets | $910.1M | +194.8% |
| Current Liabilities | $151.0M | +246.4% |
| Long-term Debt | $237.5M | +106.9% |
| Line Item | 2025-03-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$3.3M | — |
| Capital Expenditures | $20.0M | — |
| Investing Cash Flow | -$170.6M | — |
| Financing Cash Flow | $115.7M | — |
| Free Cash Flow | -$23.4M | — |
| EPS (Basic) | -$0.43 | — |
| EPS (Diluted) | -$0.43 | — |
| Total Liabilities |
| $463.3M |
| +157.7% |
| Stockholders' Equity | $446.6M | +1059.0% |